Medicis Pharmaceutical
As of the edition of 20 October 2026, Medicis Pharmaceutical runs 7 drugs, 7 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 7 |
| Total | 7 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Minocycline | none listed | 0 |
| Fluocinolone acetonide | none listed | 1 |
| Phenylbutanoic acid | none listed | 0 |
| Doxepin | none listed | 1 |
| Fluocinonide | none listed | 1 |
| Ciclopirox | none listed | 0 |
| Luliconazole | Ends 2033 (patent) | 0 |
A route B row is one company at one target.